Philips Evaluates 3D Holographic Visualization, Interaction Technology
Dutch company Royal Philips has teamed up with Israel-based RealView Imaging Ltd. to conduct a clinical study.
The pilot study has demonstrated the feasibility of using an innovative live 3D holographic visualization and interaction technology to guide minimally-invasive structural heart disease procedures, Philips said in a statement.
The study involved eight patients and was conducted in collaboration with the Schneider Children’s Medical Center in Petach Tikva, Israel.
RealView’s innovative visualization technology was used to display interactive, real-time 3D holographic images acquired by Philips’ interventional X-ray and cardiac ultrasound systems.
In addition to viewing the patient’s heart on a 2D screen, doctors in the interventional team were able to view detailed dynamic 3D holographic images of the heart ’floating in free space’ during a minimally-invasive structural heart disease procedure, without using special eyewear.
Also, the doctors were able to manipulate the projected 3D heart structures by literally touching the holographic volumes in front of them. The study demonstrated the potential of the technology to enhance the context and guidance of structural heart repairs.
The results of the study will be presented by Dr. Bruckheimer at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.